![](https://www.e-med.co.il/wp-content/uploads/2022/06/default-312x200.jpg)
Boston Scientific Announces 30-Day Safety Data From Its TAXUS IV Drug-Eluting Stent Clinical Trial
Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from its TAXUS IV clinical trial. The
Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from its TAXUS IV clinical trial. The
The first use of the Bacchus Vascular Fino Thrombectomy Catheter in the U.S. was performed on August
Medtronic, Inc. (NYSE:MDT), today announced approval by the U.S. Food and Drug Administration (FDA) of its new
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות